10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001651308-21-000223`
Period End Date	20210930
Filing Date	20211104
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	bgne-20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 91 Income Statement 84 Cash Flow Statement 95 Stockholders Equity 50 Comprehensive Income 32

Balance Sheet 91 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38B	USD	Point-in-time
Ordinary shares, shares authorized (in shares)	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.46B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$295.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.19B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$307.00K	USD	Point-in-time
Ordinary shares, shares issued (in shares)	`CommonStockSharesIssued`	1.21B	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$330.00K	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.21B	shares	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$2.53B	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$3.27B	USD	Point-in-time
Ordinary shares, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.19B	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$129.58M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$60.40M	USD	Point-in-time
Inventories	`InventoryNet`	$89.29M	USD	Point-in-time
Inventories	`InventoryNet`	$150.98M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$160.01M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$235.01M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.96B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.43B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.06M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.95M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$7.75M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$450.79M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$357.69M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$100.58M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$90.58M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.00M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$14.10M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$65.96M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$106.84M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$113.09M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$175.12M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$853.50M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$640.07M	USD	Point-in-time
Total assets	`Assets`	$5.29B	USD	Point-in-time
Total assets	`Assets`	$5.60B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$231.96M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$206.20M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$346.14M	USD	Point-in-time
Accrued expenses and other payables	`AccruedLiabilitiesCurrent`	$389.87M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$72.63M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$20.38M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$20.88M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$13.89M	USD	Point-in-time
Operating lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$18.64M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$153.84M	USD	Point-in-time
Research and development cost share liability, current portion	`ResearchAndDevelopmentCostShareLiabilityCurrentPortion`	$127.81M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.85B	CNY	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$335.01M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	$442.37M	USD	Point-in-time
Short-term debt	`LongTermDebtCurrent`	2.19B	CNY	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.08B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.30B	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$200.91M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.29B	CNY	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	$183.64M	USD	Point-in-time
Long-term bank loans	`LongTermDebtNoncurrent`	1.20B	CNY	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	-	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$52.27M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$37.61M	USD	Point-in-time
Operating lease liabilities, non-current portion	`OperatingLeaseLiabilityNoncurrent`	$29.42M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$13.27M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$10.79M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$375.04M	USD	Point-in-time
Research and development cost share liability, non-current portion	`ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion`	$266.16M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$57.43M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$54.61M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$656.32M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$624.83M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.93B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.73B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,213,234,201 and 1,190,821,941 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$118.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 1,213,234,201 and 1,190,821,941 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$121.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.72B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.41B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$6.94M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$12.58M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.38B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.55B	USD	Point-in-time
Total equity	`StockholdersEquity`	$3.36B	USD	Point-in-time
Total equity	`StockholdersEquity`	$3.87B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$5.60B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$5.29B	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$208.77M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$206.44M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$962.30M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$91.08M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$21.12M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$47.41M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$116.36M	USD	3 Qtrs
Cost of sales - product	`CostOfGoodsAndServicesSold`	$49.58M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$939.34M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.03B	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$351.94M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$349.07M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$269.23M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$391.97M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$683.62M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$160.84M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$658.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$896.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$187.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$404.00K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$668.76M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.38B	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$1.83B	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$531.22M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.17B	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-440.14M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-462.32M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-867.00M	USD	3 Qtrs
Interest (expense) income, net	`InterestIncomeExpenseNet`	$-614.00K	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNet`	$-11.28M	USD	3 Qtrs
Interest (expense) income, net	`InterestIncomeExpenseNet`	$-2.23M	USD	1 Quarter
Interest (expense) income, net	`InterestIncomeExpenseNet`	$7.18M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$29.37M	USD	3 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$5.71M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$31.48M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$26.49M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-851.78M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-433.08M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-435.04M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.14B	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-24.08M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-8.34M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-8.42M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-19.22M	USD	1 Quarter
Net loss	`ProfitLoss`	$-426.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$66.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13B	USD	3 Qtrs
Net loss	`ProfitLoss`	$-413.86M	USD	1 Quarter
Net loss	`ProfitLoss`	$-480.34M	USD	1 Quarter
Net loss	`ProfitLoss`	$-827.70M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.39M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.71M	USD	3 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-425.22M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-413.86M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-827.70M	USD	3 Qtrs
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-1.12B	USD	3 Qtrs
Loss per share attributable to BeiGene, Ltd. (in dollars per share)	`EarningsPerShareBasic`	$-0.69	USD	3 Qtrs
Loss per share attributable to BeiGene, Ltd. (in dollars per share)	`EarningsPerShareBasic`	$-0.34	USD	1 Quarter
Loss per share attributable to BeiGene, Ltd. (in dollars per share)	`EarningsPerShareBasic`	$-0.37	USD	1 Quarter
Loss per share attributable to BeiGene, Ltd. (in dollars per share)	`EarningsPerShareBasic`	$-1.07	USD	3 Qtrs
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.20B	shares	3 Qtrs
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.05B	shares	3 Qtrs
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.21B	shares	1 Quarter
Weighted average shares outstandingbasic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.15B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.15B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.21B	shares	1 Quarter
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.20B	shares	3 Qtrs
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.05B	shares	3 Qtrs
Loss per American Depositary Share ("ADS") (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$-4.46	USD	1 Quarter
Loss per American Depositary Share ("ADS") (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$-13.88	USD	3 Qtrs
Loss per American Depositary Share ("ADS") (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$-8.99	USD	3 Qtrs
Loss per American Depositary Share ("ADS") (in dollars per share)	`EarningsPerAmericanDepositorySharePerShare`	$-4.81	USD	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	88.38M	shares	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	92.77M	shares	1 Quarter
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	81.00M	shares	3 Qtrs
Weighted-average ADSs outstanding - basic (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic`	92.03M	shares	3 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	81.00M	shares	3 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	92.03M	shares	3 Qtrs
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	88.38M	shares	1 Quarter
Weighted-average ADSs outstanding - diluted (in shares)	`WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted`	92.77M	shares	1 Quarter

Cash Flow Statement 95 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-426.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$66.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13B	USD	3 Qtrs
Net loss	`ProfitLoss`	$-413.86M	USD	1 Quarter
Net loss	`ProfitLoss`	$-480.34M	USD	1 Quarter
Net loss	`ProfitLoss`	$-827.70M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$33.34M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$23.96M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$134.02M	USD	3 Qtrs
Share-based compensation expenses	`ShareBasedCompensation`	$177.70M	USD	3 Qtrs
Unrealized gains on equity investments	`IncomeLossFromEquityMethodInvestments`	$9.97M	USD	3 Qtrs
Unrealized gains on equity investments	`IncomeLossFromEquityMethodInvestments`	$17.17M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$89.50M	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$53.50M	USD	3 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-82.85M	USD	3 Qtrs
Amortization of research and development cost share liability	`AmortizationOfResearchAndDevelopmentFinancingLiability`	$-85.30M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-8.76M	USD	3 Qtrs
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-38.41M	USD	3 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$-10.16M	USD	3 Qtrs
Other items, net	`OtherOperatingActivitiesCashFlowStatement`	$17.72M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$69.17M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-10.50M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$61.69M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$6.97M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$92.94M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$58.92M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-12.38M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$21.98M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$103.60M	USD	3 Qtrs
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$819.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$124.90M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	-	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.44M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-26.72M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-790.88M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-951.13M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$82.82M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$147.96M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$4.88B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$2.06B	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$2.76B	USD	3 Qtrs
Proceeds from sale or maturity of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.97B	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$89.50M	USD	3 Qtrs
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$8.50M	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$2.02M	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$7.50M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.08B	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$531.55M	USD	3 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	$50.00M	USD	3 Qtrs
Proceeds from sale of ordinary shares, net of cost	`ProceedsFromIssuanceOfCommonStock`	$4.23B	USD	3 Qtrs
Proceeds from research and development cost share liability	`ProceedsFromResearchAndDevelopmentFinancingLiability`	$616.83M	USD	3 Qtrs
Proceeds from research and development cost share liability	`ProceedsFromResearchAndDevelopmentFinancingLiability`	-	USD	3 Qtrs
Prepayment to acquire joint venture ("JV") minority interest	`PrepaymentToAcquireJointVentureMinorityInterest`	$28.72M	USD	3 Qtrs
Prepayment to acquire joint venture ("JV") minority interest	`PrepaymentToAcquireJointVentureMinorityInterest`	-	USD	3 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$16.84M	USD	3 Qtrs
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$64.29M	USD	3 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$143.46M	USD	3 Qtrs
Proceeds from short-term loans	`ProceedsFromShortTermDebt`	$48.98M	USD	3 Qtrs
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	-	USD	3 Qtrs
Repayment of short-term loans	`RepaymentsOfShortTermDebt`	$40.23M	USD	3 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$82.19M	USD	3 Qtrs
Proceeds from option exercises and employee share purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$75.83M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$252.26M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.88B	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.34M	USD	3 Qtrs
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.77M	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-309.00K	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$848.94M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.77M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.47B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$620.77M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.47B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.46B	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$295.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$307.00K	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$330.00K	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$6.06M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.95M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$7.75M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$15.21M	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$10.60M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$41.58M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$23.40M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$41.90M	USD	3 Qtrs
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$30.93M	USD	3 Qtrs
Acquired in-process research and development included in accrued expenses	`AcquiredInProcessResearchAndDevelopmentButNotYetPaid`	$20.00M	USD	3 Qtrs
Acquired in-process research and development included in accrued expenses	`AcquiredInProcessResearchAndDevelopmentButNotYetPaid`	$45.00M	USD	3 Qtrs

Stockholders Equity 50 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.87B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.83B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.55B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.30B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.36B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.00B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.61B	USD	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.21B	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	1.19B	shares	Point-in-time
Issuance of ordinary shares in connection with collaboration	`StockIssuedDuringPeriodValueNewIssues`	$50.00M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$16.57M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$9.85M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$25.75M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$47.63M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$46.59M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units ("RSUs")	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$11.63M	USD	1 Quarter
Use of shares reserved for share option exercises and RSU releases	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$50.30M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$45.83M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$64.79M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$38.26M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$67.08M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$45.47M	USD	1 Quarter
Deconsolidation of entity	`NoncontrollingInterestDecreaseFromDeconsolidation`	$3.54M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$9.10M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$485.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.35M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$8.89M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.74M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$5.64M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-3.74M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-426.62M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$66.50M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-364.94M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.13B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-413.86M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-480.34M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-827.70M	USD	3 Qtrs
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.87B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.83B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.55B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.30B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$978.36M	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.36B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.00B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.61B	USD	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.21B	shares	Point-in-time
Balance at the end of period (in shares)	`CommonStockSharesOutstanding`	1.19B	shares	Point-in-time

Comprehensive Income 32 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-426.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$66.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-336.32M	USD	1 Quarter
Net loss	`ProfitLoss`	$-364.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13B	USD	3 Qtrs
Net loss	`ProfitLoss`	$-413.86M	USD	1 Quarter
Net loss	`ProfitLoss`	$-480.34M	USD	1 Quarter
Net loss	`ProfitLoss`	$-827.70M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$10.14M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$664.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$7.53M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$6.53M	USD	3 Qtrs
Pension liability adjustments	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$111.00K	USD	1 Quarter
Pension liability adjustments	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	3 Qtrs
Pension liability adjustments	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Pension liability adjustments	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-250.00K	USD	3 Qtrs
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.14M	USD	3 Qtrs
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.04M	USD	1 Quarter
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-68.00K	USD	1 Quarter
Unrealized holding (loss) gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$184.00K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-413.37M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.12B	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-417.52M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-822.06M	USD	3 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.17M	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-3.58M	USD	3 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-822.06M	USD	3 Qtrs
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-416.34M	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-413.37M	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-1.12B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.